The Future of Idiopathic Pulmonary Fibrosis Treatment

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

In this video from CME Corner shared in 2016, Dr. Steven Nathan is joined by two prominent pulmonologists, Dr. Marilyn Glassberg and Dr. David Lederer, to participate in a roundtable discussion about the progress against idiopathic pulmonary fibrosis (IPF).

Find out about eight ongoing research projects for pulmonary fibrosis.

The group talks about the diagnosis of the disease via CAT scans and some of the reasons why patients may develop idiopathic pulmonary fibrosis and the prevalence of the condition. The panel also discusses co-morbidities of IPF and the need to continue with regular CAT scans to spot any further health implications, along with future drugs available for IPF and the necessity of patients participating in clinical trials.

Discover the six main diagnostic tools needed for pulmonary fibrosis.

Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.